4//SEC Filing
Sacks Natalie 4
Accession 0001209191-21-064441
CIK 0001708493other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 4:03 PM ET
Size
5.6 KB
Accession
0001209191-21-064441
Insider Transaction Report
Form 4
Sacks Natalie
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2021-11-11+155,000→ 155,000 totalExercise: $7.73Exp: 2031-11-11→ Common Stock (155,000 underlying)
Footnotes (1)
- [F1]Fifty percent of the stock option shall be fully vested and exercisable on the first anniversary of the vesting commencement date, November 11, 2022, and thereafter twenty-five percent of the stock option shall vest on each May 11, 2023, and November 11, 2023.
Documents
Issuer
Harpoon Therapeutics, Inc.
CIK 0001708493
Entity typeother
Related Parties
1- filerCIK 0001683811
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 4:03 PM ET
- Size
- 5.6 KB